22157.jpg
Menopausal Disorders (MD) Competitive Landscape Report 2023: Bayer Emerges as the Top Sponsor, Backing 15 Trials, Followed by Astellas Pharma with 13 Trials
23 janv. 2024 08h23 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Menopausal Disorders (MD) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.The report offers a data-driven insight...
Global Women’s Health Market
Global $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Region
11 janv. 2024 12h43 HE | Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Women's Health Market Size, Share & Trends Analysis Report by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis &...
Global Menopausal Hot Flashes Market
Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
05 janv. 2024 21h58 HE | Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel...
22157.jpg
Menopause Market Insights, Epidemiology and Forecasts, 2019-2022 and 2023-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom, and Japan
15 déc. 2023 05h33 HE | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Menopause - Market Insights, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report...
 SheVari4™
Cepham's SheVari4™ Marks a Milestone in Women's Health Research and Development
07 déc. 2023 16h31 HE | Cepham
SOMERSET, N.J., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Cepham, a leader in Ayurvedic nutraceuticals research, is announcing the development of SheVari4™, a pioneering and patent-pending ingredient...
Mithra logo.jpg
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
30 nov. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target...
PatchMD-logo.png
PatchMD Announce New Content Resource Center on Menopause to Offer Women Advice on Symptoms, Signs, and The Latest Treatments
29 nov. 2023 09h00 HE | PatchMD
Las Vegas, Nevada, Nov. 29, 2023 (GLOBE NEWSWIRE) -- PatchMD, innovative vitamin patches designed to optimize an individual’s daily nutrient intake, is proud to announce the launch of the new...
22157.jpg
Exploring Booming Global Women's Health Apps Market: New Comprehensive Report Released
20 nov. 2023 05h18 HE | Research and Markets
Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Women's Health App: Global Markets" report has been added to ResearchAndMarkets.com's offering.In this report, the global women's health apps market...
Global Vaginal Rejuvenation Market
Global Vaginal Rejuvenation Market Analysis Report 2023-2030 Featuring Key Players - Almirall, Alma Lasers, Lutronic, Fotona, ThermiGen, vConfidence, BTL Group, Venus Concept, & Hologic
18 oct. 2023 09h33 HE | Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Vaginal Rejuvenation Market Size, Share & Trends Analysis Report By Treatment Type (Reconstructive Vaginal Rejuvenation, Cosmetic Vaginal...
Azure logo new flatter arc-1200.png
Azure Biotech Announces Educational Initiative to Create Awareness of Unmet Women’s Menopausal Medical Issue
30 août 2023 12h55 HE | Azure Biotech
RIVER VALE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Azure Biotech, Inc., a privately held women’s health company that is developing novel formulations of lasofoxifene for vulvovaginal atrophy (VVA),...